Environment and Communications Committee (Iceland)

Local Media Consortium Releases 2022 Member Economic Impact Report

Retrieved on: 
목요일, 5월 26, 2022

NEW YORK, May 26, 2022  /PRNewswire/ --  The Local Media Consortium, a strategic alliance of local media companies, today announced the release of its second annual member economic impact report, which quantifies how its strength-in-numbers business model helps local newspapers, broadcasters and online outlets maximize digital cost savings and increase revenue for long-term sustainability through strategic partnerships with digital platforms and service providers.

Key Points: 
  • The report finds year-over-year gains in each of the economic impact report metrics, including a 21% increase in cumulative revenue and cost savings, and a 34% increase in member engagements with the LMC's 30 partners .
  • "The Local Media Consortium was created to help the local media industry coalesce to minimize costs, maximize digital revenue and strengthen their means to serve an important community need," said Fran Wills, CEO of the LMC.
  • The LMC's member economic impact report finds that in 2021 ad serving with Google Ad Manager delivered the highest expense savings and significant programmatic advertising growth for members.
  • The Local Media Consortium delivers economic value through strategic partnerships on behalf of more than 100 local media companies in top markets across the United States, Canada, and Puerto Rico, and includes more than 5,000 newspaper, radio, TV and online only news outlets.

University of Phoenix Alum Dr. De La Peña Llaca’s Holoportation Technology and Expertise Featured in NASA Project

Retrieved on: 
목요일, 5월 5, 2022

University of Phoenix celebrates the success of alum Dr. Fernando De La Pea Llaca in bringing holoportation technology to medicine in space.

Key Points: 
  • University of Phoenix celebrates the success of alum Dr. Fernando De La Pea Llaca in bringing holoportation technology to medicine in space.
  • I have 28 years of experience leading technology companies; however, space exploration has always motivated me, shares De La Pea Llaca.
  • De La Pea Llaca established AEXA Aerospace in 2012, at the same time he began his master's degree at University of Phoenix.
  • The NASA surgeon agreed and supported the effort, and the result was the successful October 2021 testing of the holoportation technology.

FRANdata President Edith Wiseman Appointed to International Franchise Association's Board of Director's Executive Committee

Retrieved on: 
목요일, 3월 10, 2022

ARLINGTON, Va., March 10, 2022 /PRNewswire-PRWeb/ --The International Franchise Association (IFA) has announced the appointment of Edith Wiseman, the President of FRANdata to serve on its Board of Directors' Executive Committee following her being elected as the Supplier Forum Chair.

Key Points: 
  • ARLINGTON, Va., March 10, 2022 /PRNewswire-PRWeb/ --The International Franchise Association (IFA) has announced the appointment of Edith Wiseman, the President of FRANdata to serve on its Board of Directors' Executive Committee following her being elected as the Supplier Forum Chair.
  • This leadership role gives Ms. Wiseman a platform for levering franchise insight to further the growth of franchising.
  • "The 2022 class of IFA Board members consists of new and diverse perspectives," said IFA President and CEO Matt Haller.
  • "I am grateful and proud to lead the Supplier Forum as its chair this year," said Edith Wiseman, President of FRANdata.

SoCalGas Applauds Establishment of First Renewable Gas Standard in the United States

Retrieved on: 
목요일, 2월 24, 2022

The action taken by the CPUC today makes California the first state in the country to adopt a renewable gas standard.

Key Points: 
  • The action taken by the CPUC today makes California the first state in the country to adopt a renewable gas standard.
  • Under this new renewable gas standard, SoCalGas will be required to replace 12.2 percent of the traditional gas it delivers to core customers with renewable gas by 2030.
  • The standard also sets an interim goal of procuring approximately 3 percent renewable gas by 2025.
  • As part of that net zero goal, SoCalGas established benchmarks including delivering 20 percent renewable natural gas (RNG) by 2030.

CHRIS STROISCH JOINS NICB AS VICE PRESIDENT, PUBLIC AFFAIRS AND COMMUNICATIONS

Retrieved on: 
화요일, 2월 15, 2022

DES PLAINES, Ill., Feb. 15, 2022 /PRNewswire/ --The National Insurance Crime Bureau(NICB) , the insurance industry's association dedicated to predicting, preventing, and prosecuting insurance crime, announces the hiring of Chris Stroisch as Vice President, Public Affairs and Communications.

Key Points: 
  • DES PLAINES, Ill., Feb. 15, 2022 /PRNewswire/ --The National Insurance Crime Bureau(NICB) , the insurance industry's association dedicated to predicting, preventing, and prosecuting insurance crime, announces the hiring of Chris Stroisch as Vice President, Public Affairs and Communications.
  • Stroisch brings with him nearly 20 years of public relations, marketing, and communications experience, more than a decade of which was leading public relations and communications teams in the insurance industry.
  • The National Insurance Crime Bureau announces the hiring of Chris Stroisch as VP, Public Affairs and Communications.
  • He also served as Director, Public Relations and Writing Services, leading internal and external communications for Horace Mann Insurance.

BluePrints CEO Elected to Three-Year Term on VetPartners Board of Directors

Retrieved on: 
화요일, 1월 25, 2022

BluePrints Veterinary Marketing Group CEO and Founder Robin Brogdon, MA , has been elected to a three-year term on the Board of Directors of VetPartners.

Key Points: 
  • BluePrints Veterinary Marketing Group CEO and Founder Robin Brogdon, MA , has been elected to a three-year term on the Board of Directors of VetPartners.
  • The news was announced at the 2022 VetPartners Annual Meeting in Orlando, FL, held January 12-14.
  • Established in 2002, VetPartners is a nonprofit association of more than 300 professionals dedicated to serving the veterinary profession.
  • Brogdon has been involved in VetPartners for 15 years, joining the same year she launched BluePrints.

Goulston & Storrs Attorney Rebecca Tunney Named a 2022 "Up & Coming Lawyer" by Massachusetts Lawyers Weekly

Retrieved on: 
화요일, 1월 18, 2022

BOSTON, Jan. 18, 2022 /PRNewswire/ -- Goulston & Storrs , an Am Law 200 firm, is pleased to announce that Rebecca Tunney has been named a 2022 "Up & Coming Lawyer" by Massachusetts Lawyers Weekly.

Key Points: 
  • BOSTON, Jan. 18, 2022 /PRNewswire/ -- Goulston & Storrs , an Am Law 200 firm, is pleased to announce that Rebecca Tunney has been named a 2022 "Up & Coming Lawyer" by Massachusetts Lawyers Weekly.
  • Born in Victoria, British-Columbia and raised in Ottawa, Ontario, Canada, Tunney has particular experience with Canadian-U.S. estate planning and has built a significant cross-border trusts and estates practice.
  • She also serves as Co-Chair of the Communications Committee for the Boston Bar Association, Trusts & Estates section and as the Book Review Editor for the Massachusetts Bar Association's Massachusetts Law Review Journal.
  • We are a place where mutual respect and collaboration drive open discussion, transparency, creativity and optimal results for our clients.

Wade Patterson Is 2022 IAAO President

Retrieved on: 
월요일, 1월 17, 2022

KANSAS CITY, Mo., Jan. 17, 2022 /PRNewswire/ --L. Wade Patterson assumed the office of President of the International Association of Assessing Officers (IAAO) on Jan. 1, 2022.

Key Points: 
  • KANSAS CITY, Mo., Jan. 17, 2022 /PRNewswire/ --L. Wade Patterson assumed the office of President of the International Association of Assessing Officers (IAAO) on Jan. 1, 2022.
  • As IAAO 2022 President, Mr. Patterson is Chair of the Board of Directors and presides at all meetings of the Board and membership.
  • He served as IAAO President-Elect in 2021, Vice President in 2020, and was on the IAAO Board of Directors from 2016-2018.
  • Mr. Patterson was on the Board of Directors of the Oklahoma IAAO Chapter and served as president in 2004-05; and on Oklahoma Assessor's Association Board of Directors, serving as president in 2009.

Fate Therapeutics Announces Abstract Highlighting FT538 and FT573 Programs Selected for Presentation at SITC 2021 Annual Meeting Press Conference

Retrieved on: 
화요일, 11월 9, 2021

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the Society for Immunotherapy of Cancer (SITC) Communications Committee selected an abstract featuring preclinical data from the Company’s FT538 and FT573 programs for showcase at the SITC 2021 Annual Meeting Press Conference. The selected abstract entitled “Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo” will be presented by Jeffrey S. Miller, M.D., Professor of Medicine, University of Minnesota and Deputy Director, Masonic Cancer Center. The press conference is being held on Wednesday, November 10 from 12:30-2 pm ET.

Key Points: 
  • The published data demonstrate that FT538 exhibits significantly enhanced serial killing and functional persistence compared to peripheral blood NK cells.
  • ET to highlight its emerging pipeline of off-the-shelf, multiplexed-engineered, iPSC-derived NK cell programs for the treatment of solid tumors.
  • In order to participate in the conference call, please dial (877) 303-6235 (domestic) or (631) 291-4837 (international) and refer to conference ID 2793475.
  • Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer.

Apexigen To Host Key Opinion Leader Webinar on Sotigalimab in Post-Anti-PD-(L)1 Melanoma

Retrieved on: 
화요일, 11월 9, 2021

SAN CARLOS, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced that it will host a key opinion leader (KOL) webinar on the therapeutic potential of sotigalimab in post-anti-PD-(L)1 melanoma, the Company’s lead immuno-oncology candidate, on Friday, November 19, 2021 at 11:00 a.m. ET. Sotigalimab is a potentially first-in-class and best-in-class CD40 agonist, with unique epitope specificity and Fc receptor engagement for optimal therapeutic effect and tolerability.

Key Points: 
  • Sotigalimab is a potentially first-in-class and best-in-class CD40 agonist, with unique epitope specificity and Fc receptor engagement for optimal therapeutic effect and tolerability.
  • The webinar will feature a presentation by KOL Harriet Kluger, M.D., from the Yale School of Medicine.
  • Dr. Kluger will discuss the current treatment landscape and unmet medical need in treating patients with post-anti-PD-(L)1 melanoma and the sotigalimab phase 2 data in post-PD-1(L)1 patients.
  • Dr. Kluger and Apexigens Chief Medical Officer, Frank Hsu, M.D., will also lead a discussion on the most recent Phase 2 sotigalimab melanoma data.